Sean Josefosky

Quality Assurance - Materials Management at Marker Therapeutics - Houston, TX, US

Sean Josefosky's Contact Details
HQ
713-400-6400
Location
Houston, Texas, United States
Company
Marker Therapeutics
Sean Josefosky's Company Details
Marker Therapeutics logo, Marker Therapeutics contact details

Marker Therapeutics

Houston, TX, US • 50 - 99 Employees
Major Drugs

We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient's immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies. Marker is also advancing a number of innovative peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including our Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and our HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In parallel, we are developing a proprietary DNA expression technology named PolyStart™ to improve the ability of the cellular immune system to recognize and destroy diseased cells.

Immunotherapy T Cell Based Therapies
Details about Marker Therapeutics
Frequently Asked Questions about Sean Josefosky
Sean Josefosky currently works for Marker Therapeutics.
Sean Josefosky's role at Marker Therapeutics is Quality Assurance - Materials Management.
Sean Josefosky's email address is ***@markertherapeutics.com. To view Sean Josefosky's full email address, please signup to ConnectPlex.
Sean Josefosky works in the Major Drugs industry.
Sean Josefosky's colleagues at Marker Therapeutics are Janki Gabani, Victoria Bolotina, Tsvetelina Pencheva Hoang, Anastasiya Yermakova, Samuel C., Tsvetelina Hoang, Nadia Agopyan and others.
Sean Josefosky's phone number is 713-400-6400
See more information about Sean Josefosky